Combining conventional therapy with immunotherapy: A risky business?

Title
Combining conventional therapy with immunotherapy: A risky business?
Authors
Keywords
Immunotherapy, Tumor immunology, Chemotherapy, Combination, Survival
Journal
EUROPEAN JOURNAL OF CANCER
Volume 113, Issue -, Pages 41-44
Publisher
Elsevier BV
Online
2019-04-06
DOI
10.1016/j.ejca.2019.02.014

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now